'On consolidated basis
Quarter ended September 2025 compared with Quarter ended September 2024.
Net sales (including other operating income) of Alkem Laboratories has increased 17.17% to Rs 4000.99 crore. Operating profit margin has jumped from 22.05% to 23.01%, leading to 22.31% rise in operating profit to Rs 920.77 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 26.03% to 22.77%. Purchase of finished goods cost rose from 10.21% to 11.86%. Employee cost increased from 17.61% to 17.86%. Other expenses fell from 24.43% to 24.36%.
Other income fell 22.90% to Rs 103.69 crore. PBIDT rose 15.46% to Rs 1024.46 crore. Provision for interest rose 24.45% to Rs 35.02 crore. Loan funds rose to Rs 2,355.60 crore as of 30 September 2025 from Rs 1,477.90 crore as of 30 September 2024. Inventories rose to Rs 3,007...
Pleaselogin & subscribe to view the full report.
More Reports
|
|